ZCM
ANIP icon

Ziegler Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Ziegler Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$629K Buy
9,093
+539
+6% +$32.5K 0.02% 332
2023
Q4 		$472K Hold
8,554
– – 0.02% 358
2023
Q3 		$497K Sell
8,554
-54
-0.6% -$3.12K 0.02% 347
2023
Q2 		$463K Buy
+8,608
New +$382K 0.02% 355

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ziegler Capital Management's ANIP Position: Q1 2024 in Review

Ziegler Capital Management increased its ANI Pharmaceuticals (ANIP) stake by 6.3% in Q1 2024, buying an estimated $32.5K and bringing the position to 9,093 shares worth $629K. The position accounts for 0.02% of the portfolio, ranked #332.

Ziegler Capital Management first reported a position in ANIP in Q2 2023 and has held it in 4 quarters since. 200 funds tracked by Wall St. Rank hold ANIP as of Q1 2024.

  • Ziegler Capital Management held 9,093 shares of ANI Pharmaceuticals worth $629K as of Q1 2024.
  • Ziegler Capital Management bought 539 ANI Pharmaceuticals shares in Q1 2024, an estimated $32.5K.
  • ANI Pharmaceuticals made up 0.02% of Ziegler Capital Management's portfolio in Q1 2024, its #332 holding.
  • Ziegler Capital Management first reported a position in ANI Pharmaceuticals in Q2 2023 and has held it in 4 quarters since.
  • 200 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.